Amplia Therapeutics Shares Rally 17% on Fourth Confirmed Response in Pancreatic Cancer Trial
Amplia Therapeutics Shares Rally 17% on Fourth Confirmed Response in Pancreatic Cancer Trial
Amplia Therapeutics 的股票在胰腺癌試驗中第四次獲得確認響應後上漲了17%
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊